Crescent Biopharma, Inc.CBIONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P14
Within normal range
vs 5Y Ago
-5.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -130.02% |
| 2024 | 10.84% |
| 2023 | 24.92% |
| 2022 | 19.19% |
| 2021 | -46.50% |
| 2020 | 24.51% |
| 2019 | -19.97% |
| 2018 | -45.56% |
| 2017 | -0.12% |
| 2016 | -260.73% |